| Secondary |
| Antiplatelet Therapy |
25.6% |
| Diffuse Large B-cell Lymphoma |
24.4% |
| Amaurosis Fugax |
10.3% |
| Myocardial Infarction |
7.7% |
| Prophylaxis |
6.4% |
| Stent Placement |
5.1% |
| Aortic Aneurysm |
3.8% |
| Colorectal Cancer |
3.8% |
| Hypertension |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Cerebrovascular Accident |
1.3% |
| Knee Arthroplasty |
1.3% |
| Malaria Prophylaxis |
1.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.3% |
| Psoriasis |
1.3% |
| Small Cell Lung Cancer Extensive Stage |
1.3% |
|
| Cerebrovascular Accident |
11.1% |
| Death |
7.4% |
| Pulmonary Embolism |
7.4% |
| Pyrexia |
7.4% |
| Subarachnoid Haemorrhage |
7.4% |
| Transient Ischaemic Attack |
7.4% |
| Drug Hypersensitivity |
3.7% |
| Haematochezia |
3.7% |
| Headache |
3.7% |
| Hypercalcaemia |
3.7% |
| Hypertensive Crisis |
3.7% |
| Pneumonia Aspiration |
3.7% |
| Pulmonary Haemorrhage |
3.7% |
| Renal Failure |
3.7% |
| Renal Function Test Abnormal |
3.7% |
| Renal Impairment |
3.7% |
| Thrombocytopenia |
3.7% |
| White Blood Cell Count |
3.7% |
| Wound Complication |
3.7% |
| Xiith Nerve Injury |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.8% |
| Hypertension |
8.7% |
| Prophylaxis |
7.8% |
| Diffuse Large B-cell Lymphoma |
6.2% |
| Product Used For Unknown Indication |
6.2% |
| Non-small Cell Lung Cancer |
5.4% |
| Multiple Myeloma |
4.8% |
| Rheumatoid Arthritis |
4.8% |
| Diabetes Mellitus |
4.1% |
| Pain |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.0% |
| Breast Cancer |
2.8% |
| Colitis Ulcerative |
2.6% |
| Gastric Cancer |
2.6% |
| Colorectal Cancer |
2.4% |
| Depression |
2.4% |
| Osteoporosis |
2.3% |
| Angina Pectoris |
2.2% |
| Renal Transplant |
2.2% |
|
| Vomiting |
10.9% |
| Death |
10.3% |
| Pyrexia |
7.9% |
| Myocardial Infarction |
6.7% |
| Pneumonia |
6.1% |
| Pulmonary Embolism |
6.1% |
| Dyspnoea |
5.5% |
| Thrombocytopenia |
5.5% |
| Transient Ischaemic Attack |
4.8% |
| Deep Vein Thrombosis |
3.6% |
| Nausea |
3.6% |
| Renal Failure |
3.6% |
| Urosepsis |
3.6% |
| Uveitis |
3.6% |
| Dehydration |
3.0% |
| Diarrhoea |
3.0% |
| General Physical Health Deterioration |
3.0% |
| Orthostatic Hypotension |
3.0% |
| Pseudomonas Infection |
3.0% |
| Syncope |
3.0% |
|
| Interacting |
| Chronic Obstructive Pulmonary Disease |
44.4% |
| Acute Myocardial Infarction |
22.2% |
| Pulmonary Embolism |
22.2% |
| Prophylaxis |
11.1% |
|
| Oesophageal Ulcer |
50.0% |
| Oesophageal Ulcer Haemorrhage |
50.0% |
|
